Maywufa Company Ltd. (TPE:1731)
Taiwan
· Delayed Price · Currency is TWD 21.80
-0.20 (-0.91%)
At close: Mar 9, 2026
Maywufa Company Revenue
In the year 2025, Maywufa Company had annual revenue of 1.58B TWD with 6.61% growth. Maywufa Company had revenue of 414.83M in the quarter ending December 31, 2025, with 10.30% growth.
Revenue
1.58B
Revenue Growth
+6.61%
P/S Ratio
1.83
Revenue / Employee
7.07M
Employees
224
Market Cap
2.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.58B | 98.19M | 6.61% |
| Dec 31, 2024 | 1.49B | 185.15M | 14.23% |
| Dec 31, 2023 | 1.30B | 55.62M | 4.47% |
| Dec 31, 2022 | 1.25B | -44.11M | -3.42% |
| Dec 31, 2021 | 1.29B | 223.89M | 21.02% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PhytoHealth | 134.58M |
| Johnson Chemical Pharmaceutical Works | 567.06M |
| Allied Biotech | 821.81M |
| Merdury Biopharmaceutical | 246.00K |
| Easywell Biomedicals | 588.89M |
| LIWANLI Innovation | 125.54M |
| Golden Biotechnology | 44.58M |
| Orient EuroPharma | 4.53B |